AXA Venture Partners (AVP) is a venture capital firm with its presence in several countries has invested in many high-growth technology companies. In a recent development, the venture capital firm has announced that it has raised €130 million in its second Early Stage Fund.
Similar to the Early Stage I funding of €200 million that it received in 2015, the Early Stage II fund will also be used to focus on Europe, North America and Israel. It will focus mainly on consumer platforms, enterprise SaaS and SME solutions in the digital health and fintech sectors.